Psychostimulants play a major role in fatal strokes among young adults

April 03, 2019

An estimated 76 million people use psychostimulants, which include illicit drugs such as methamphetamine, cocaine, and 3,4-methylenedioxymethamphetamine, as well as prescription stimulants. A new Journal of Forensic Sciences study from Australia is the first to present national data of psychostimulant use in young adults who experienced a fatal stroke.

Investigators found that from 2009-2016, psychostimulant users constituted nearly a fifth of the 279 cases of fatal stroke in adults aged 15-44 years, the majority of which had evidence of consumption immediately prior to the fatal stroke.

Methamphetamine was overwhelmingly the drug implicated. The median methamphetamine concentration was similar to that reported for all methamphetamine-related deaths in Australia but less than half that of deaths attributed solely to methamphetamine toxicity. This suggests that high concentrations are not essential to cause a methamphetamine-related stroke.

Cases of haemorrhagic stroke were also documented involving other illicit and licit psychostimulants. In no cases were medications for attention deficit hyperactivity disorder identified.

"This is the first study to show the major role that psychostimulants play in causing fatal strokes amongst young adults," said lead author Prof. Shane Darke, of the University of New South Wales, in Australia. "All of these deaths were preventable. Users of these drugs, however, appear to be largely unaware of the risk. Psychostimulant users, and those treating them, need to be aware of their elevated stroke risk, which may have devastating consequences."
-end-


Wiley

Related Methamphetamine Articles from Brightsurf:

Study explores link between methamphetamine use and risky sexual behavior
Recreational use of the illicit drug methamphetamine has long been associated with increases in overall impatient and risky behavior.

Impact of methamphetamine use depends on your genes
The research, published in Molecular Psychiatry found that variations in the gene known as BDNF strongly determine the effects of methamphetamine in the brain.

Co-addiction of meth and opioids hinders treatment
A study published in the Journal of Substance Abuse Treatment found that methamphetamine use was associated with more than twice the risk for dropping out of treatment for opioid-use disorder.

Mapping international drug use through the world's largest wastewater study
A seven-year project monitoring illicit drug use in 37 countries via wastewater samples shows that cocaine use was skyrocketing in Europe in 2017 and Australia had a serious problem with methamphetamine.

A rat's brain, on and off methamphetamine
Drug addiction is a vicious cycle of reward and withdrawal.

The science Of Breaking Bad: Would you know if meth was cooked inside your house?
Researchers analysed the contamination levels in household items from a home suspected to have previously been used for cooking methamphetamine, to determine whether surface wipe samples can adequately establish contamination and define the health risks.

Spending on illicit drugs in US nears $150 billion annually
Spending on cannabis, cocaine, heroin and methamphetamine fluctuated between $120 billion and $145 billion each year from 2006 to 2016, rivaling what Americans spend each year on alcohol, according to a new study.

Psychostimulants play a major role in fatal strokes among young adults
An estimated 76 million people use psychostimulants, which include illicit drugs such as methamphetamine, cocaine, and 3,4-methylenedioxymethamphetamine, as well as prescription stimulants.

New study examines the way estrogen affects methamphetamine addiction
MUSC researchers look at how methamphetamine affects female rats in a new study published January 10 eNeuro.

New study suggests ovarian hormone may make drug withdrawal symptoms worse for women
Researchers found that a form of the estrogen hormone can contribute to drug relapse in females by worsening withdrawal symptoms.

Read More: Methamphetamine News and Methamphetamine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.